Target intelligence / Profile preview

N-acetyltransferase 8 (NAT8)

Target
NAT8
Molecular classification
Enzyme, Acetyltransferase
01

Overview

N-acetyltransferase 8 is an enzyme encoded by the NAT8 gene and is primarily expressed in the kidney and liver[1]. NAT8 resides in the endoplasmic reticulum, where it acts as a lysine N-acetyltransferase, catalyzing the N6-acetylation of lysine residues on various proteins using acetyl-CoA as a donor[1][2][5]. It also acetylates the free alpha-amino group of cysteine S-conjugates, contributing to the formation of mercapturic acids—important for the detoxification and excretion of reactive electrophiles[1][5]. NAT8 is implicated in the regulation of apoptosis and protein homeostasis (notably reticulophagy), and may also influence amyloid beta-peptide secretion through acetylation of BACE1 in neurons[1][5]. Mutations in NAT8 are associated with chronic kidney disease and rare syndromes such as Xia-Gibbs syndrome and iminoglycinuria[1][2].

Other names
N-acetyltransferase 8NAT8ATase2CML1GLAHcml1TSC501TSC510CCNATCamello-like protein 1Cysteinyl-conjugate N-acetyltransferaseProtein-lysine N6-acetyltransferase 8
02

Mechanism of action

Acetylation of lysine residues on proteins in the endoplasmic reticulum, Acetylation of cysteine S-conjugates to form mercapturic acids

03

Biological functions

Protein acetylationRegulation of apoptosisDetoxification (mercapturic acid formation)Regulation of protein homeostasisReticulophagy
04

Disease associations

Chronic kidney diseaseXia-Gibbs syndromeIminoglycinuriaPotential roles in amyloid beta-peptide regulation
05

Safety considerations

Possible roles in protein homeostasis and kidney disease may suggest caution in therapeutic modulation, but no specific concerns highlighted in primary literature

Beyond the preview

Go deeper on N-acetyltransferase 8 (NAT8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-acetyltransferase 8 (NAT8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call